Navigation Links
Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009
Date:11/2/2009

OVERLAND PARK, Kan., Nov. 2 /PRNewswire/ -- Vince and Associates Clinical Research (VACR), a leading provider of Phase I-IV clinical research trials, announced that Dr. Bradley Vince, Medical Director and President, shared his expertise at the Exploratory Development World Congress on October 20, 2009 in Boston, Massachusetts. The Exploratory Development World Americas Congress focuses on early development strategy, including a wide range of disciplines within clinical trials including Clinical Research, Clinical Pharmacology, Phase I Trials, Exploratory Development, Regulatory Affairs, PK/PD and Clinical Operations.

The pre-conference workshop facilitated by Lorraine M. Rusch, PhD, Vice President of Business Development at VACR, was entitled Mitigating Risk in Early Clinical Development. During the session, Dr. Vince discussed Recruiting Strategies and Medical Oversight of Special Population Volunteers in Early Stage Trials. Dr. Vince related his physician perspective on the recruitment and medical management of intent-to-treat populations during early clinical research trials which enable earlier Proof of Concept (POC) drug development data to be successfully obtained.

"As a multi-specialty research unit, Vince and Associates Clinical Research is a leading provider of Phase I-IV clinical research for the pharmaceutical and biotechnology industry," said Dr. Vince. "We welcomed the opportunity to share our perspective, medical expertise and strength in early-stage drug development data at the Exploratory Development World Congress."

As the Medical Director of the Vince and Associates Clinical Research, Dr. Vince provides overall management of Phase I-IV clinical pharmacology services, including study design, feasibility, recruiting and monitoring of both healthy normal subjects and special population patients participating in clinical trials at the Overland Park, Kansas facilities.

Vince and Associates Clinical Research is a dedicated research facility that conducts Phase I-IV clinical trials for the global pharmaceutical and biotech industry. Dr. Vince has personally assembled an experienced team that focuses on quality research data and exceptional customer service while maintaining the highest ethical and professional standards. Vince and Associates has become one of the premier U.S. clinical research sites specializing in multispecialty trials. With over 275 clinical trials completed and having worked with over 70 sponsors and CROs, Vince and Associates is well known and respected for its rapid study start-up and quality study data.

Additional background materials pertaining to Vince and Associates Clinical Research is located on the corporate website at www.vinceandassociates.com.

    Bruce Copeland
    913-696-1601
    bcopeland@vinceandassociates.com

SOURCE Vince and Associates Clinical Research


'/>"/>
SOURCE Vince and Associates Clinical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vincent W. Renz Joins NewCardio as President
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Physiotherapy Associates Marks National Physical Therapy Month With Free Educational Brochure
6. Aprimas EHR Helps Bend Urology Associates Improve Efficiency, Workflow
7. Press Ganey Partners With Health Management Associates
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):